Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis

Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis

IntroductionLimited data from clinical trials in multiple sclerosis (MS) reported that minocycline, a widely used antibiotic belonging to the family of tetracyclines (TCs), exerts a beneficial short-lived clinical effect A similar anti-inflammatory effect of minocycline attributed to a deviation fro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Despoina T. Florou, Athanasios Mavropoulos, Efthymios Dardiotis, Vana Tsimourtou, Vasileios Siokas, Athina-Maria Aloizou, Christos Liaskos, Christina Tsigalou, Christina Katsiari, Lazaros I. Sakkas, Georgios Hadjigeorgiou, Dimitrios P. Bogdanos
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
multiple sclerosis
doxycycline
minocycline
proinflammatory
interferon-γ
interleukin-17
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/ed1c5b548c154cf3805e7e12acf07aed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/ed1c5b548c154cf3805e7e12acf07aed

Ejemplares similares